Story · Medicine & Biotech
Juan Osorio: Can We Harness CD40 Agonism to Treat Bladder Cancer?
1 outlet · first reported by OncoDaily on
Juan Osorio, Assistant Attending at Memorial Sloan Kettering Cancer Center and Director of Clinical Operations and Translational Immunology at The Rockefeller University, shared on LinkedIn: “Excited to share our new (OncoDaily)
Coverage, in order
-
Juan Osorio: Can We Harness CD40 Agonism to Treat Bladder Cancer?Juan Osorio, Assistant Attending at Memorial Sloan Kettering Cancer Center and Director of Clinical Operations and Translational Immunology at The Rockefeller University, shared on LinkedIn: “Excited to share our new
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.